Company intelligence / Profile preview

PharmaSens

Biel, Bern, Switzerland

Ownership: Private
Development stage: Other

Overview

PharmaSens has successfully submitted an FDA approval application for its innovative insulin pump system (“niia essential”), after earning ISO 13485 certification; no published clinical trial results yet, products not commercially launched.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Medical device/pump development and manufacturing communityunspecified but likely with diabetes technology/product development partners

Beyond the preview

Go deeper on PharmaSens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaSens.

Explore the full profile